← Open Payments lookup

ROBERT WALLEN: Open Payments

NPI 1609583517 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,415 in 131 payments from 17 companies in 2025. Trend: 2023 $29 · 2024 $833 · 2025 $2,415

Food & beverage: $2,415
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)30$476
ABBVIE INC.34$435
Indivior Inc.9$250
Vanda Pharmaceuticals Inc.13$234
Alkermes, Inc.6$132
Braeburn Inc.5$128
E.R. Squibb & Sons, L.L.C.3$119
Teva Pharmaceuticals USA, Inc.5$103
Neurocrine BioSciences, Inc.3$97
Corium, LLC7$82

Products named: CAPLYTA, VRAYLAR, SUBLOCADE, FANAPT, BRIXADI, COBENFY, INGREZZA, Azstarys.

Industry payments across AZ — which companies pay providers there.